GLP-1 diabetes and weight-loss drug side effects: Ozempic face and more, Harvard Health Publishing Cleveland Clinic Health Library
therefore, it was used as a control antagonist
Though Retatrutide is not yet FDA-approved, its potential effectiveness shows great promise, as evidenced by the TRIUMPH-1 Phase 3 trials that demonstrated up to 28.3% weight loss over 80 weeks
Used in research on how GIP , GLP-1 , and glucagon receptors work together
If you struggle to eat enough at all, ask your doctor about a dose adjustment, since adequate nutrition is essential for your health
Besides these metabolic effects, GLP-1 drugs also appear to have an impact on brain health and mental health